0000078003-25-000042.txt : 20250212 0000078003-25-000042.hdr.sgml : 20250212 20250212145121 ACCESSION NUMBER: 0000078003-25-000042 CONFORMED SUBMISSION TYPE: SCHEDULE 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20250212 DATE AS OF CHANGE: 20250212 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Zura Bio Ltd CENTRAL INDEX KEY: 0001855644 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-92696 FILM NUMBER: 25614306 BUSINESS ADDRESS: STREET 1: 4225 EXECUTIVE SQUARE STREET 2: SUITE 600 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-247-0520 MAIL ADDRESS: STREET 1: 4225 EXECUTIVE SQUARE STREET 2: SUITE 600 CITY: LA JOLLA STATE: CA ZIP: 92037 FORMER COMPANY: FORMER CONFORMED NAME: JATT Acquisition Corp DATE OF NAME CHANGE: 20210407 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: PFIZER INC CENTRAL INDEX KEY: 0000078003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 135315170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G/A BUSINESS ADDRESS: STREET 1: 66 HUDSON BOULEVARD EAST CITY: NEW YORK STATE: NY ZIP: 10001-2192 BUSINESS PHONE: 2127332323 MAIL ADDRESS: STREET 1: 66 HUDSON BOULEVARD EAST CITY: NEW YORK STATE: NY ZIP: 10001-2192 FORMER COMPANY: FORMER CONFORMED NAME: PFIZER CHARLES & CO INC DATE OF NAME CHANGE: 19710908 SCHEDULE 13G/A 1 primary_doc.xml SCHEDULE 13G/A 0000078003-23-000060 0000078003 XXXXXXXX LIVE 1 Class A Ordinary Shares, $0.0001 par value per share 12/31/2024 0001855644 Zura Bio Limited G9TY5A101 4225 Executive Square, Suite 600 La Jolla CA 92037 Rule 13d-1(d) Pfizer Inc. 13-5315170 DE 2970022.00 0.00 2970022.00 0.00 2970022.00 N 4.6 CO (See row 11) Based on 65,293,530 shares of Class A Ordinary Shares, outstanding as of November 4, 2024 reported in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2024, filed with the U.S. Securities and Exchange Commission on November 7, 2024 (File No. 001-40598). Zura Bio Limited 4225 Executive Square, Suite 600, La Jolla, CA, 92037 Pfizer Inc. ("Pfizer") 66 Hudson Boulevard East, New York, NY 10001 Delaware, U.S.A. Y See rows 5 though 11 on the cover page. N Y Y Y Y Y Y Pfizer Inc. 13-5315170 /s/ Madelyn D. Purcell 02/12/2025